Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Envoy Medical (COCH) Short term Debt (2022 - 2023)

Envoy Medical's Short term Debt history spans 2 years, with the latest figure at $311000.0 for Q4 2023.

On a quarterly basis, Short term Debt fell 7.16% to $311000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $311000.0, a 7.16% decrease, with the full-year FY2023 number at $311000.0, down 7.16% from a year prior.
Short term Debt hit $311000.0 in Q4 2023 for Envoy Medical, up from $228000.0 in the prior quarter.
Over the last five years, Short term Debt for COCH hit a ceiling of $335000.0 in Q4 2022 and a floor of $228000.0 in Q3 2023.